Details for Patent: 8,419,307
✉ Email this page to a colleague
Which drugs does patent 8,419,307 protect, and when does it expire?
Patent 8,419,307 protects AXIRON and is included in one NDA.
This patent has seventeen patent family members in fourteen countries.
Summary for Patent: 8,419,307
| Title: | Spreading implement |
| Abstract: | Described are methods comprising applying a liquid pharmaceutical testosterone composition with an implement comprising a support and a receptacle mounted on the support and defining a reservoir space with an open top to receive the liquid, wherein the receptacle includes a flexible membrane integrally forming a base and a wall, the wall being substantially transverse to the base and having a working surface to spread the liquid over the treatment surface, wherein the base has a continuous surface such that liquid cannot pass through the base, wherein the wall includes an inner portion which extends from the base to an upper end and an outer skirt portion, wherein the inner portion and skirt portion form a double-wall structure, and wherein at least the wall is resiliently deformable so the working surface maintains contact with the treatment surface when spreading the liquid. |
| Inventor(s): | Bayly; Peter (Victoria, AU), Bayly; Mark Simon (Victoria, AU), Ahlstrom; Magnus (Victoria, AU), Watkinson; Adam Charles (Victoria, AU) |
| Assignee: | Acrux DDS Pty Ltd. (West Melbourne, Victoria, AU) |
| Application Number: | 13/464,556 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,419,307 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent 8,419,307
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF A PERSON IN NEED THEREOF | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,419,307
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007343579 | ⤷ Try a Trial | |||
| Brazil | PI0720945 | ⤷ Try a Trial | |||
| Canada | 2674661 | ⤷ Try a Trial | |||
| China | 101636194 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 015473 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 200900987 | ⤷ Try a Trial | |||
| European Patent Office | 2106272 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
